1[1]Blum JL,Jones SE,Buzdar AU,et al.Multicenter phase Ⅱ study of capecitabine in paclitaxel-refractory metastatic breast cancer[J].J Clin Oncol,1999,17(2):485.
1[1]Budman DR, Meropol NJ, Reiger B, et al. Preliminary studies of a novel fluoropyrimidine carbamate: Capecitabine [J]. J Clin Oncol, 1998, 16: 1795-1802.
2[2]Mackean MJ, Planting AS, Twelves C, et al. A Phase I and pharmacologic study of intermittent twice daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer [J]. J Clin Oncol, 1998, 16: 2977-2985.
3Blum JL,Buzdar AM,Dieras V,et al.A multicenter phase II trial of Xeloda (capecitabine) in taxane-refractory metastatic breast cancer[].Proceedings of the American Society of Clinical Oncology.1999
4Ishikawa T,Sekiguchi F,Fukase Y,et al.Positive correlation between the efficacy of capecitabine and doxifluridine and the ration of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts[].Cancer Research.1998
5Miwa M,Ura M,Nishida M,et al.Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue[].European Journal of Cancer.1998
6O′Reilly SM,Moiseyenko V,Talbot DC,et al.A randomized phase II study of Xeloda ( capecitabine) vs paclitaxel in breast cancer patients failing previous anthracycline therapy[].Proceedings of the American Society of Clinical Oncology.1998
7Wang ZW,Wong KK,Chew L,et al.Capecitabine as an oral chemotherapeutic agent in the treatment of refractory metastatic breast carcinoma (MBC)[].Proceedings of the American Society of Clinical Oncology.2000
8Cervantes G,Torrecillas L,Eraro AA,et al.Capecitabine (Xeloda) as treatment after failure to taxanes for metastatic breast cancer[].Proceedings of the American Society of Clinical Oncology.2000
9Ishikawa T,Utoh M,Sawada N,et al.Tumor seletive delivery of 5fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts[].Biochemical Pharmacology.1998
10Blum JL,Jones SE,Buzdar AU,et al.Multicenter phase II study of capecitabine in paclitaxel refractory metastatic breast cancer[].Journal of Clinical Oncology.1999
10Courneya KS, Friedenreich CM. Physical exercise and quality of life following cancer diagnosis:a literature review. Annals of Behavioural Medicine, 1999, 21: 171-179.
